| Mr Jeffrey Scott Moore, LCSW | |
|
430 E 450 S, Clearfield, UT 84015-1736 | |
| (801) 540-8054 | |
| (801) 776-4162 |
| Full Name | Mr Jeffrey Scott Moore |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 430 E 450 S, Clearfield, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013233345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6229733501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jeffrey Scott Moore, LCSW 1637 E 1470 S, Ogden, UT 84404-6087 Ph: (801) 540-8054 | Mr Jeffrey Scott Moore, LCSW 430 E 450 S, Clearfield, UT 84015-1736 Ph: (801) 540-8054 |
News Archive
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalization and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency announced today.
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the successful closing of a US $11 million series B investment. The financing round was led by new investor Gilde Healthcare Partners, a leading European life sciences investor, who joins existing investor Index Ventures. Dirk Kersten from Gilde will join the company's Supervisory Board.
Integrated DNA Technologies (IDT) will host a talk on maximizing efficiency of NGS enrichment panels at the qPCR & NGS 2015 Advanced Molecular Diagnostics for Biomarker Discovery Symposium on Monday March 23rd at 3PM. The talk will detail current technical issues faced by researchers when using hybridization enrichment panels and provide practical advice on how to increase successes while reducing time and costs in targeted sequencing.
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death.
› Verified 9 days ago
Mrs. Jeanne Marie Hansel, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 466 N Main St, Clearfield, UT 84015 Phone: 801-915-0329 Fax: 801-915-0329 | |
Linda Rhees, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 466 N Main St, Clearfield, UT 84015 Phone: 801-604-1316 Fax: 801-649-0964 | |
Mr. Paul W. Dawson, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 49 E 200 S, Clearfield, UT 84015 Phone: 801-779-0095 Fax: 801-779-0255 | |
Jay A. Eldredge, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 49 E 200 S, Clearfield, UT 84015 Phone: 801-779-0095 | |
Brandy Lynn Routson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 129 S State St Ste 250, Clearfield, UT 84015 Phone: 801-855-7999 Fax: 801-855-7999 | |
Joel Campbell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 466 N Main St Ste 210, Clearfield, UT 84015 Phone: 801-603-2547 Fax: 801-649-0964 |